Clinical Trials List
2021-03-17 - 2028-12-31
Phase III
Recruiting7
-
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/23
Investigators and Locations
Co-Principal Investigator
- Tung-Liang Lin Division of Hematology & Oncology
- Hung Chang Division of Hematology & Oncology
- Ming-Chung Kao Division of Hematology & Oncology
- 林潔 Division of Nuclear Medicine
- 陳建誠 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Sin-Syue Li Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Ya-Ting Hsu Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hao-Yuan Wang Division of Hematology & Oncology
- 吳嘉紘 Division of Radiology
- Ting-An Lin Division of Hematology & Oncology
- Po-Shen Ko Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- 高智平 Division of Hematology & Oncology
- 陳蓉宣 Division of Radiology
- Chia-Jen Liu Division of Hematology & Oncology
- Yao-Chung Liu Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Wei-Ching Lin Division of Radiology
- Ming-Yu Lien Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hui-Ching Wang Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- 高育青 Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- SHAN-CHI YU Division of Others -
- - - Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- Wen-Chien Chou Division of Others -
- Chien-Chin Lin Division of Others -
- HSIN-AN HOU Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- KUAN-YIN KO Division of Nuclear Medicine
- 柯紀綸 Division of Radiology
- - - Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- 劉高郎 Division of Radiology
- CHENG-HONG TSAI Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
500 participants
